Search

Search Constraints

You searched for: Author/Creator Passo, Murray H.

Search Results

1. A1: Clinical Inactive Disease in the Pediatric Rheumatology Care and Outcomes Improvement Network Cohort: Which Components of Clinical Inactive Disease Do Patients Not Achieve?. Issue Volume 66:Issue(2014)supplement 3 (March 2014)

2. Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Issue 3 (24th January 2019)

3. A68: The Role of Serum S100A12 Protein Levels in Maintaining Inactive Disease on Anti‐tumor Necrosis Factor Therapy in Polyarticular Forms of Juvenile Idiopathic Arthritis. Issue 11 (March 2014)

4. A20: Understanding the Use and Biology of TNF Therapy in JIA—Clinical Outcomes. Issue 11 (March 2014)

5. A44: High Levels of DEK Autoantibodies May Predict Early Flare Following Cessation of Anti‐TNF Therapy. Issue 11 (March 2014)

6. A12: The Role of Serum S100A12 Protein Levels in Disease Flare After Withdrawal of Anti‐tumor Necrosis Factor Therapy in Polyarticular Forms of Juvenile Idiopathic Arthritis. Issue 11 (March 2014)

7. A151: Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Performance Improvement on Juvenile Idiopathic Arthritis Quality Measures. Issue 11 (March 2014)

8. A180: A Population Management Tool for Proactive Care of Juvenile Idiopathic Arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network. Issue 11 (March 2014)

9. A1: Clinical Inactive Disease in the Pediatric Rheumatology Care and Outcomes Improvement Network Cohort: Which Components of Clinical Inactive Disease Do Patients Not Achieve?. Issue 11 (March 2014)

10. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis. Issue 6 (25th April 2019)